STAT

STAT+: AstraZeneca’s experimental COPD treatment posts strong results in late-stage studies

STAT+: AstraZeneca’s experimental COPD treatment posts strong results in late-stage studiesWorldPing

An experimental COPD drug from AstraZeneca could prove competitive with existing treatments, and have a slice of the market to itself.

This is a short WorldPing brief. The full report was published by STAT.

Read the full report at STAT

More coverage: all health news on WorldPing.

Related news

The Verge
WorldPing
The Verge

Google’s Atlas of the human genome could pave the way for new treatments

Google DeepMind has unveiled an AI tool that its scientists claim could help unravel the mysteries of the human genome and transform our understanding of biology, accelerating scientific research and ultimately paving the way for new treatments for diseases.

Brief by WorldPing · Original reporting by The Verge